Nutrition and Colon Cancer

Nutrition in the Prevention and Treatment of Disease

Volumn , Issue , 2013, Pages 697-715

  Gallaher, Daniel D ^a   Trudo, Sabrina P ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84885137920     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-391884-0.00037-8     Document Type: Chapter

References (218)

1. American Cancer Society Colorectal cancer facts & figures 2011, American Cancer Society, Atlanta, GA.
2. Grulich A.E., McCredie M., Coates M. Cancer incidence in Asian migrants to New South Wales, Australia. Br. J. Cancer 1995, 71:400-408.
3. Schottenfeld D., Fraumeni J.F. Cancer Epidemiology and Prevention 2006, Oxford University Press, New York.
4. Gervaz P., Bucher P., Morel P. Two colons-two cancers: paradigm shift and clinical implications. J. Surg. Oncol. 2004, 88:261-266.
5. Wei E.K., Giovannucci E., Wu K., Rosner B., Fuchs C.S., Willett W.C., et al. Comparison of risk factors for colon and rectal cancer. Int. J. Cancer 2004, 108:433-442.
6. Lu S., Chiu Y.S., Smith A.P., Moore D., Lee N.M. Biomarkers correlate with colon cancer and risks: a preliminary study. Dis. Colon Rectum 2009, 52:715-724.
7. Zhao C., Ivanov I., Dougherty E.R., Hartman T.J., Lanza E., Bobe G., et al. Noninvasive detection of candidate molecular biomarkers in subjects with a history of insulin resistance and colorectal adenomas. Cancer Prev. Res. 2009, 2:590-597.
8. Steinmetz K.A., Potter J.D. Vegetables, fruit, and cancer: I. Epidemiology. Cancer Causes Control 1991, 2:325-357.
9. Ramos S. Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. J. Nutr. Biochem. 2007, 18:427-442.
10. Pan M.H., Lai C.S., Wu J.C., Ho C.T. Molecular mechanisms for chemoprevention of colorectal cancer by natural dietary compounds. Mol. Nutr. Food Res. 2011, 55:32-45.
11. Pan M.H., Ho C.T. Chemopreventive effects of natural dietary compounds on cancer development. Chem. Soc. Rev. 2008, 37:2558-2574.
12. Mates J.M., Segura J.A., Alonso F.J., Marquez J. Anticancer antioxidant regulatory functions of phytochemicals. Curr. Med. Chem. 2011, 18:2315-2338.
13. Johnson W.W. Cytochrome P450 inactivation by pharmaceuticals and phytochemicals: therapeutic relevance. Drug Metab. Rev. 2008, 40:101-147.
14. Steinkellner H., Rabot S., Freywald C., Nobis E., Scharf G., Chabicovsky M., et al. Effects of cruciferous vegetables and their constituents on drug metabolizing enzymes involved in the bioactivation of DNA-reactive dietary carcinogens. Mutat. Res. 2001, 480-481:285-297.
15. Pool-Zobel B., Veeriah S., Bohmer F.D. Modulation of xenobiotic metabolising enzymes by anticarcinogens: focus on glutathione S-transferases and their role as targets of dietary chemoprevention in colorectal carcinogenesis. Mutat. Res. 2005, 591:74-92.
16. Tan A.C., Konczak I., Sze D.M., Ramzan I. Molecular pathways for cancer chemoprevention by dietary phytochemicals. Nutr. Cancer 2011, 63:495-505.
17. Saracino M.R., Lampe J.W. Phytochemical regulation of UDP-glucuronosyltransferases: implications for cancer prevention. Nutr. Cancer 2007, 59:121-141.
18. Harris R.M., Waring R.H. Sulfotransferase inhibition: potential impact of diet and environmental chemicals on steroid metabolism and drug detoxification. Curr. Drug Metab. 2008, 9:269-275.
19. Terzic J., Grivennikov S., Karin E., Karin M. Inflammation and colon cancer. Gastroenterology 2010, 138:2101-2114.e5.
20. World Cancer Research Fund/American Institute for Cancer Research Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective 2007, American Institute for Cancer Research, Washington, DC.
21. Howe G.R., Benito E., Castelleto R., Cornee J., Esteve J., Gallagher R.P., et al. Dietary intake of fiber and decreased risk of cancers of the colon and rectum: evidence from the combined analysis of 13 case-control studies. J. Natl. Cancer Inst. 1992, 84:1887-1896.
22. Slattery M.L., Potter J.D., Coates A., Ma K.N., Berry T.D., Duncan D.M., et al. Plant foods and colon cancer: an assessment of specific foods and their related nutrients (United States). Cancer Causes Control 1997, 8:575-590.
23. Shannon J., White E., Shattuck A.L., Potter J.D. Relationship of food groups and water intake to colon cancer risk. Cancer Epidemiol. Biomarkers Prev. 1996, 5:495-502.
24. Terry P., Giovannucci E., Michels K.B., Bergkvist L., Hansen H., Holmberg L., et al. Fruit, vegetables, dietary fiber, and risk of colorectal cancer. J. Natl. Cancer Inst. 2001, 93:525-533.
25. Park Y., Subar A.F., Kipnis V., Thompson F.E., Mouw T., Hollenbeck A., et al. Fruit and vegetable intakes and risk of colorectal cancer in the NIH-AARP diet and health study. Am. J. Epidemiol. 2007, 166:170-180.
26. World Cancer Research Fund Food, Nutrition and the Prevention of Cancer: A Global Perspective 1997, American Institute for Cancer Research, Washington, DC.
27. Liu R.H. Potential synergy of phytochemicals in cancer prevention: mechanism of action. J. Nutr. 2004, 134:3479S-3485S.
28. Boateng J., Verghese M., Shackelford L., Walker L.T., Khatiwada J., Ogutu S., et al. Selected fruits reduce azoxymethane (AOM)-induced aberrant crypt foci (ACF) in Fisher 344 male rats. Food Chem. Toxicol. 2007, 45:725-732.
29. Harris G.K., Gupta A., Nines R.G., Kresty L.A., Habib S.G., Frankel W.L., et al. Effects of lyophilized black raspberries on azoxymethane-induced colon cancer and 8-hydroxy-2′-deoxyguanosine levels in the Fischer 344 rat. Nutr. Cancer 2001, 40:125-133.
30. Poulsen M., Mortensen A., Binderup M.L., Langkilde S., Markowski J., Dragsted L.O. The effect of apple feeding on markers of colon carcinogenesis. Nutr. Cancer 2011, 63:402-409.
31. Yang Y., Gallaher D.D. Effect of dried plums on colon cancer risk factors in rats. Nutr. Cancer 2005, 53:117-125.
32. Arikawa A.Y., Gallaher D.D. Cruciferous vegetables reduce morphological markers of colon cancer risk in dimethylhydrazine-treated rats. J. Nutr. 2008, 138:526-532.
33. Kassie F., Rabot S., Uhl M., Huber W., Qin H.M., Helma C., et al. Chemoprotective effects of garden cress (Lepidium sativum) and its constituents towards 2-amino-3-methyl-imidazo[4,5-f]quinoline (IQ)-induced genotoxic effects and colonic preneoplastic lesions. Carcinogenesis 2002, 23:1155-1161.
34. Kassie F., Uhl M., Rabot S., Grasl-Kraupp B., Verkerk R., Kundi M., et al. Chemoprevention of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ)-induced colonic and hepatic preneoplastic lesions in the F344 rat by cruciferous vegetables administered simultaneously with the carcinogen. Carcinogenesis 2003, 24:255-261.
35. Temple N.J., Basu T.K. Selenium and cabbage and colon carcinogenesis in mice. J. Natl. Cancer Inst. 1987, 79:1131-1134.
36. Sengupta A., Ghosh S., Das S. Tomato and garlic can modulate azoxymethane-induced colon carcinogenesis in rats. Eur. J. Cancer Prev. 2003, 12:195-200.
37. Chihara T., Shimpo K., Kaneko T., Beppu H., Mizutani K., Higashiguchi T., et al. Inhibition of 1,2-dimethylhydrazine-induced mucin-depleted foci and O-methylguanine DNA adducts in the rat colorectum by boiled garlic powder. Asian Pacific J. Cancer Prev. 2010, 11:1301-1304.
38. Cheng J.Y., Meng C.L., Tzeng C.C., Lin J.C. Optimal dose of garlic to inhibit dimethylhydrazine-induced colon cancer. World J. Surg. 1995, 19:621-626.
39. Tache S., Ladam A., Corpet D.E. Chemoprevention of aberrant crypt foci in the colon of rats by dietary onion. Eur. J. Cancer 2007, 43:454-458.
40. Hakkak R., Korourian S., Ronis M.J., Johnston J.M., Badger T.M. Soy protein isolate consumption protects against azoxymethane-induced colon tumors in male rats. Cancer Lett. 2001, 166:27-32.
41. Badger T.M., Ronis M.J., Simmen R.C., Simmen F.A. Soy protein isolate and protection against cancer. J. Am. Coll. Nutr. 2005, 24:146S-149S.
42. Faris M.A., Takruri H.R., Shomaf M.S., Bustanji Y.K. Chemopreventive effect of raw and cooked lentils (Lens culinaris L) and soybeans (Glycine max) against azoxymethane-induced aberrant crypt foci. Nutr. Res. 2009, 29:355-362.
43. Murillo G., Choi J.K., Pan O., Constantinou A.I., Mehta R.G. Efficacy of garbanzo and soybean flour in suppression of aberrant crypt foci in the colons of CF-1 mice. Anticancer Res. 2004, 24:3049-3055.
44. Ohuchi Y., Myojin Y., Shimamoto F., Kashimoto N., Kamiya K., Watanabe H. Decrease in size of azoxymethane induced colon carcinoma in F344 rats by 180-day fermented miso. Oncol. Rep. 2005, 14:1559-1564.
45. Bobe G., Barrett K.G., Mentor-Marcel R.A., Saffiotti U., Young M.R., Colburn N.H., et al. Dietary cooked navy beans and their fractions attenuate colon carcinogenesis in azoxymethane-induced ob/ob mice. Nutr. Cancer 2008, 60:373-381.
46. Theodoratou E., Kyle J., Cetnarskyj R., Farrington S.M., Tenesa A., Barnetson R., et al. Dietary flavonoids and the risk of colorectal cancer. Cancer Epidemiol. Biomarkers Prev. 2007, 16:684-693.
47. Kyle J.A., Sharp L., Little J., Duthie G.G., McNeill G. Dietary flavonoid intake and colorectal cancer: a case-control study. Br. J. Nutr. 2010, 103:429-436.
48. Rossi M., Negri E., Parpinel M., Lagiou P., Bosetti C., Talamini R., et al. Proanthocyanidins and the risk of colorectal cancer in Italy. Cancer Causes Control 2010, 21:243-250.
49. Satia J.A., Tseng M., Galanko J.A., Martin C., Sandler R.S. Dietary patterns and colon cancer risk in whites and African Americans in the North Carolina Colon Cancer Study. Nutr. Cancer 2009, 61:179-193.
50. Annema N., Heyworth J.S., McNaughton S.A., Iacopetta B., Fritschi L. Fruit and vegetable consumption and the risk of proximal colon, distal colon, and rectal cancers in a case-control study in Western Australia. J. Am. Diet. Assoc. 2011, 111:1479-1490.
51. Kim M.K., Park J.H. Conference on "Multidisciplinary Approaches to Nutritional Problems": Symposium on "Nutrition and Health." Cruciferous vegetable intake and the risk of human cancer: epidemiological evidence. Proc. Nutr. Soc. 2009, 68:103-110.
52. Nomura A.M., Wilkens L.R., Murphy S.P., Hankin J.H., Henderson B.E., Pike M.C., et al. Association of vegetable, fruit, and grain intakes with colorectal cancer: the Multiethnic Cohort Study. Am. J. Clin. Nutr. 2008, 88:730-737.
53. van Duijnhoven F.J., Bueno De Mesquita H.B., Ferrari P., Jenab M., Boshuizen H.C., Ros M.M., et al. Fruit, vegetables, and colorectal cancer risk: the European Prospective Investigation into Cancer and Nutrition. Am. J. Clin. Nutr. 2009, 89:1441-1452.
54. Simons C.C., Hughes L.A., Arts I.C., Goldbohm R.A., van den Brandt P.A., Weijenberg M.P. Dietary flavonol, flavone and catechin intake and risk of colorectal cancer in the Netherlands Cohort Study. Int. J. Cancer 2009, 125:2945-2952.
55. Koushik A., Hunter D.J., Spiegelman D., Beeson W.L., van den Brandt P.A., Buring J.E., et al. Fruits, vegetables, and colon cancer risk in a pooled analysis of 14 cohort studies. J. Natl. Cancer Inst. 2007, 99:1471-1483.
56. Aune D., Lau R., Chan D.S., Vieira R., Greenwood D.C., Kampman E., et al. Nonlinear reduction in risk for colorectal cancer by fruit and vegetable intake based on meta-analysis of prospective studies. Gastroenterology 2011, 141:106-118.
57. Yan L., Spitznagel E.L., Bosland M.C. Soy consumption and colorectal cancer risk in humans: a meta-analysis. Cancer Epidemiol. Biomarkers Prev. 2010, 19:148-158.
58. Adams K.F., Lampe P.D., Newton K.M., Ylvisaker J.T., Feld A., Myerson D., et al. Soy protein containing isoflavones does not decrease colorectal epithelial cell proliferation in a randomized controlled trial. Am. J. Clin. Nutr. 2005, 82:620-626.
59. Turesky R.J. Formation and biochemistry of carcinogenic heterocyclic aromatic amines in cooked meats. Toxicol. Lett. 2007, 168:219-227.
60. Barrett J.H., Smith G., Waxman R., Gooderham N., Lightfoot T., Garner R.C., et al. Investigation of interaction between N-acetyltransferase 2 and heterocyclic amines as potential risk factors for colorectal cancer. Carcinogenesis 2003, 24:275-282.
61. Santarelli R.L., Pierre F., Corpet D.E. Processed meat and colorectal cancer: a review of epidemiologic and experimental evidence. Nutr. Cancer 2008, 60:131-144.
62. de Kok T.M., van Maanen J.M. Evaluation of fecal mutagenicity and colorectal cancer risk. Mutat. Res. 2000, 463:53-101.
63. Whittemore A.S., Wu-Williams A.H., Lee M., Zheng S., Gallagher R.P., Jiao D.A., et al. Diet, physical activity, and colorectal cancer among Chinese in North America and China. J. Natl. Cancer Inst. 1990, 82:915-926.
64. Kune G.A., Kune S. The nutritional causes of colorectal cancer: an introduction to the Melbourne study. Nutr. Cancer 1987, 9:1-4.
65. Fujise T., Iwakiri R., Kakimoto T., Shiraishi R., Sakata Y., Wu B., et al. Long-term feeding of various fat diets modulates azoxymethane-induced colon carcinogenesis through Wnt/beta-catenin signaling in rats. Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 292:G1150-G1156.
66. McIntosh G.H., Regester G.O., Le Leu R.K., Royle P.J., Smithers G.W. Dairy proteins protect against dimethylhydrazine-induced intestinal cancers in rats. J. Nutr. 1995, 125:809-816.
67. Pence B.C., Butler M.J., Dunn D.M., Miller M.F., Zhao C., Landers M. Non-promoting effects of lean beef in the rat colon carcinogenesis model. Carcinogenesis 1995, 16:1157-1160.
68. Nutter R.L., Gridley D.S., Kettering J.D., Goude A.G., Slater J.M. BALB/c mice fed milk or beef protein: differences in response to 1,2-dimethylhydrazine carcinogenesis. J. Natl. Cancer Inst. 1983, 71:867-874.
69. Parnaud G., Peiffer G., Tache S., Corpet D.E. Effect of meat (beef, chicken, and bacon) on rat colon carcinogenesis. Nutr. Cancer 1998, 32:165-173.
70. Kettunen H.L., Kettunen A.S., Rautonen N.E. Intestinal immune responses in wild-type and Apcmin/+ mouse, a model for colon cancer. Cancer Res. 2003, 63:5136-5142.
71. Pierre F., Freeman A., Tache S., Van der Meer R., Corpet D.E. Beef meat and blood sausage promote the formation of azoxymethane-induced mucin-depleted foci and aberrant crypt foci in rat colons. J. Nutr. 2004, 134:2711-2716.
72. Sesink A.L., Termont D.S., Kleibeuker J.H., Van Der Meer R. Red meat and colon cancer: dietary haem, but not fat, has cytotoxic and hyperproliferative effects on rat colonic epithelium. Carcinogenesis 2000, 21:1909-1915.
73. Sesink A.L., Termont D.S., Kleibeuker J.H., Van der Meer R. Red meat and colon cancer: dietary haem-induced colonic cytotoxicity and epithelial hyperproliferation are inhibited by calcium. Carcinogenesis 2001, 22:1653-1659.
74. Chan D.S., Lau R., Aune D., Vieira R., Greenwood D.C., Kampman E., et al. Red and processed meat and colorectal cancer incidence: meta-analysis of prospective studies. PloS One 2011, 6:e20456.
75. Alexander D.D., Cushing C.A. Red meat and colorectal cancer: a critical summary of prospective epidemiologic studies. Obes. Rev. 2011, 12:e472-e493.
76. Cross A.J., Ferrucci L.M., Risch A., Graubard B.I., Ward M.H., Park Y., et al. A large prospective study of meat consumption and colorectal cancer risk: an investigation of potential mechanisms underlying this association. Cancer Res. 2010, 70:2406-2414.
77. Bastide N.M., Pierre F.H., Corpet D.E. Heme iron from meat and risk of colorectal cancer: a meta-analysis and a review of the mechanisms involved. Cancer Prev. Res. 2011, 4:177-184.
78. Joshi A.D., Corral R., Siegmund K.D., Haile R.W., Le Marchand L., Martinez M.E., et al. Red meat and poultry intake, polymorphisms in the nucleotide excision repair and mismatch repair pathways and colorectal cancer risk. Carcinogenesis 2009, 30:472-479.
79. Girard H., Butler L.M., Villeneuve L., Millikan R.C., Sinha R., Sandler R.S., et al. UGT1A1 and UGT1A9 functional variants, meat intake, and colon cancer, among Caucasians and African-Americans. Mutat. Res. 2008, 644:56-63.
80. Butler L.M., Millikan R.C., Sinha R., Keku T.O., Winkel S., Harlan B., et al. Modification by N-acetyltransferase 1 genotype on the association between dietary heterocyclic amines and colon cancer in a multiethnic study. Mutat. Res. 2008, 638:162-174.
81. Newmark H.L., Wargovich M.J., Bruce W.R. Colon cancer and dietary fat, phosphate, and calcium: a hypothesis. J. Natl. Cancer Inst. 1984, 72:1323-1325.
82. Govers M.J., Van der Meet R. Effects of dietary calcium and phosphate on the intestinal interactions between calcium, phosphate, fatty acids, and bile acids. Gut 1993, 34:365-370.
83. Govers M.J., Termont D.S., Lapre J.A., Kleibeuker J.H., Vonk R.J., Van der Meer R. Calcium in milk products precipitates intestinal fatty acids and secondary bile acids and thus inhibits colonic cytotoxicity in humans. Cancer Res. 1996, 56:3270-3275.
84. Chakrabarty S., Wang H., Canaff L., Hendy G.N., Appelman H., Varani J. Calcium sensing receptor in human colon carcinoma: interaction with Ca(2+) and 1,25-dihydroxyvitamin D(3). Cancer Res. 2005, 65:493-498.
85. Powell S.M., Zilz N., Beazer-Barclay Y., Bryan T.M., Hamilton S.R., Thibodeau S.N., et al. APC mutations occur early during colorectal tumorigenesis. Nature 1992, 359:235-237.
86. Cadigan K.M., Peifer M. Wnt signaling from development to disease: insights from model systems. Cold Spring Harbor Perspect Biol. 2009, 1:a002881. -a002881.
87. Larriba M.J., Ordonez-Moran P., Chicote I., Martin-Fernandez G., Puig I., Munoz A., et al. Vitamin D receptor deficiency enhances Wnt/beta-catenin signaling and tumor burden in colon cancer. PLoS One 2011, 6:e23524.
88. Kelley N.S., Hubbard N.E., Erickson K.L. Conjugated linoleic acid isomers and cancer. J. Nutr. 2007, 137:2599-2607.
89. Beppu F., Hosokawa M., Tanaka L., Kohno H., Tanaka T., Miyashita K. Potent inhibitory effect of trans9, trans11 isomer of conjugated linoleic acid on the growth of human colon cancer cells. J. Nutr. Biochem. 2006, 17:830-836.
90. Cho H.J., Kim W.K., Jung J.I., Kim E.J., Lim S.S., Kwon D.Y., et al. Trans-10,cis-12, not cis-9,trans-11, conjugated linoleic acid decreases ErbB3 expression in HT-29 human colon cancer cells. World J. Gastroenterol. 2005, 11:5142-5150.
91. Hannun Y.A., Obeid L.M. The ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind. J. Biol. Chem. 2002, 277:25847-25850.
92. Lemonnier L.A., Dillehay D.L., Vespremi M.J., Abrams J., Brody E., Schmelz E.M. Sphingomyelin in the suppression of colon tumors: prevention versus intervention. Arch. Biochem. Biophys. 2003, 419:129-138.
93. Yoshida S., Ye X. The binding ability of bovine milk caseins to mutagenic heterocyclic amines. J. Dairy Sci. 1992, 75:958-961.
94. Gourley G.R., Kreamer B.L., Cohnen M. Inhibition of beta-glucuronidase by casein hydrolysate formula. J. Pediatr. Gastroenterol. Nutr. 1997, 25:267-272.
95. Bounous G., Gervais F., Amer V., Batist G., Gold P. The influence of dietary whey protein on tissue glutathione and the diseases of aging. Clin. Invest. Med. 1989, 12:343-349.
96. Tavan E., Cayuela C., Antoine J.M., Trugnan G., Chaugier C., Cassand P. Effects of dairy products on heterocyclic aromatic amine-induced rat colon carcinogenesis. Carcinogenesis 2002, 23:477-483.
97. Hakkak R., Korourian S., Ronis M.J., Johnston J.M., Badger T.M. Dietary whey protein protects against azoxymethane-induced colon tumors in male rats. Cancer Epidemiol. Biomarkers Prev. 2001, 10:555-558.
98. Xiao R., Carter J.A., Linz A.L., Ferguson M., Badger T.M., Simmen F.A. Dietary whey protein lowers serum C-peptide concentration and duodenal SREBP-1c mRNA abundance, and reduces occurrence of duodenal tumors and colon aberrant crypt foci in azoxymethane-treated male rats. J. Nutr. Biochem. 2006, 17:626-634.
99. Snow D.R., Jimenez-Flores R., Ward R.E., Cambell J., Young M.J., Nemere I., et al. Dietary milk fat globule membrane reduces the incidence of aberrant crypt foci in Fischer-344 rats. J. Agric. Food Chem. 2010, 58:2157-2163.
100. Corpet D.E., Pierre F. How good are rodent models of carcinogenesis in predicting efficacy in humans? A systematic review and meta-analysis of colon chemoprevention in rats, mice and men. Eur. J. Cancer 2005, 41:1911-1922.
101. Liu Y., Ju J., Xiao H., Simi B., Hao X., Reddy B.S., et al. Effects of combination of calcium and aspirin on azoxymethane-induced aberrant crypt foci formation in the colons of mice and rats. Nutr. Cancer 2008, 60:660-665.
102. Newmark H.L., Yang K., Lipkin M., Kopelovich L., Liu Y., Fan K., et al. A Western-style diet induces benign and malignant neoplasms in the colon of normal C57Bl/6 mice. Carcinogenesis 2001, 22:1871-1875.
103. Newmark H.L., Yang K., Kurihara N., Fan K., Augenlicht L.H., Lipkin M. Western-style diet-induced colonic tumors and their modulation by calcium and vitamin D in C57Bl/6 mice: a preclinical model for human sporadic colon cancer. Carcinogenesis 2009, 30:88-92.
104. 3 inhibits promotion by intrarectal instillation of lithocholic acid in N-methyl-N-nitrosourea-induced colonic tumorigenesis in rats. Carcinogenesis 1989, 10:647-649.
105. Huerta S., Irwin R.W., Heber D., Go V.L., Koeffler H.P., Uskokovic M.R., et al. 1α,25-(OH)(2)-D(3) and its synthetic analogue decrease tumor load in the Apc(min) mouse. Cancer Res. 2002, 62:741-746.
106. 3 in chemically induced rat colon carcinogenesis. Carcinogenesis 1992, 13:2293-2298.
107. Sitrin M.D., Halline A.G., Abrahams C., Brasitus T.A. Dietary calcium and vitamin D modulate 1,2-dimethylhydrazine-induced colonic carcinogenesis in the rat. Cancer Res. 1991, 51:5608-5613.
108. Irving A.A., Halberg R.B., Albrecht D.M., Plum L.A., Krentz K.J., Clipson L., et al. Supplementation by vitamin D compounds does not affect colonic tumor development in vitamin D sufficient murine models. Arch. Biochem. Biophys. 2011, 515:64-71.
109. Huncharek M., Muscat J., Kupelnick B. Colorectal cancer risk and dietary intake of calcium, vitamin D, and dairy products: a meta-analysis of 26,335 cases from 60 observational studies. Nutr. Cancer 2009, 61:47-69.
110. Yin L., Grandi N., Raum E., Haug U., Arndt V., Brenner H. Meta-analysis: longitudinal studies of serum vitamin D and colorectal cancer risk. Aliment. Pharmacol. Ther. 2009, 30:113-125.
111. Touvier M., Chan D.S., Lau R., Aune D., Vieira R., Greenwood D.C., et al. Meta-analyses of vitamin D intake, 25-hydroxyvitamin D status, vitamin D receptor polymorphisms, and colorectal cancer risk. Cancer Epidemiol. Biomarkers Prev. 2011, 20:1003-1016.
112. Lee J.E., Li H., Chan A.T., Hollis B.W., Lee I.M., Stampfer M.J., et al. Circulating levels of vitamin D and colon and rectal cancer: the Physicians' Health Study and a meta-analysis of prospective studies. Cancer Prev. Res. 2011, 4:735-743.
113. Lee S.A., Shu X.O., Yang G., Li H., Gao Y.T., Zheng W. Animal origin foods and colorectal cancer risk: a report from the Shanghai Women's Health Study. Nutr. Cancer 2009, 61:194-205.
114. Ruder E.H., Thiebaut A.C., Thompson F.E., Potischman N., Subar A.F., Park Y., et al. Adolescent and mid-life diet: risk of colorectal cancer in the NIH-AARP Diet and Health Study. Am. J. Clin. Nutr. 2011, 94:1607-1619.
115. Simons C.C., Leurs L.J., Weijenberg M.P., Schouten L.J., Goldbohm R.A., van den Brandt P.A. Fluid intake and colorectal cancer risk in the Netherlands Cohort Study. Nutr. Cancer 2010, 62:307-321.
116. Scharlau D., Borowicki A., Habermann N., Hofmann T., Klenow S., Miene C., et al. Mechanisms of primary cancer prevention by butyrate and other products formed during gut flora-mediated fermentation of dietary fibre. Mutat. Res. 2009, 682:39-53.
117. Pool-Zobel B.L. Inulin-type fructans and reduction in colon cancer risk: review of experimental and human data. Br. J. Nutr. 2005, 93(Suppl. 1):S73-S90.
118. Gallaher D.D., Khil J. The effect of synbiotics on colon carcinogenesis in rats. J. Nutr. 1999, 129:1483S-1487S.
119. Manning T.S., Gibson G.R. Microbial-gut interactions in health and disease: prebiotics. Best Pract. Res. Clin. Gastroenterol. 2004, 18:287-298.
120. Ju J., Picinich S.C., Yang Z., Zhao Y., Suh N., Kong A.N., et al. Cancer-preventive activities of tocopherols and tocotrienols. Carcinogenesis 2010, 31:533-542.
121. Srinivasan M., Sudheer A.R., Menon V.P. Ferulic acid: therapeutic potential through its antioxidant property. J. Clin. Biochem. Nutr. 2007, 40:92-100.
122. Adam A., Crespy V., Levrat-Verny M.A., Leenhardt F., Leuillet M., Demigne C., et al. The bioavailability of ferulic acid is governed primarily by the food matrix rather than its metabolism in intestine and liver in rats. J. Nutr. 2002, 132:1962-1968.
123. Youn M., Saari Csallany A., Gallaher D.D. Whole grain consumption has a modest effect on the development of diabetes in the Goto-Kakisaki rat. Br. J. Nutr. 2012, 107:192-201.
124. Norazalina S., Norhaizan M.E., Hairuszah I., Norashareena M.S. Anticarcinogenic efficacy of phytic acid extracted from rice bran on azoxymethane-induced colon carcinogenesis in rats. Exp. Toxicol. Pathol. 2010, 62:259-268.
125. Jenab M., Thompson L.U. The influence of phytic acid in wheat bran on early biomarkers of colon carcinogenesis. Carcinogenesis 1998, 19:1087-1092.
126. Webb A.L., McCullough M.L. Dietary lignans: potential role in cancer prevention. Nutr. Cancer 2005, 51:117-131.
127. Maziya-Dixon B.B., Klopfenstein C.F., Leipold H.W. Protective effects of hard red versus hard white winter wheats in chemically induced colon cancer in CF1 mice. Cereal Chem. 1994, 71:359-363.
128. Yu Z., Xu M., Santana-Rios G., Shen R., Izquierdo-Pulido M., Williams D.E., et al. A comparison of whole wheat, refined wheat and wheat bran as inhibitors of heterocyclic amines in the Salmonella mutagenicity assay and in the rat colonic aberrant crypt focus assay. Food Chem. Toxicol. 2001, 39:655-665.
129. Wilson R.B., Hutcheson D.P., Wideman L. Dimethylhydrazine-induced colon tumors in rats fed diets containing beef fat or corn oil with and without wheat bran. Am. J. Clin. Nutr. 1977, 30:176-181.
130. Reddy B.S., Mori H., Nicolais M. Effect of dietary wheat bran and dehydrated citrus fiber on azoxymethane-induced intestinal carcinogenesis in Fischer 344 rats. J. Natl. Cancer Inst. 1981, 66:553-557.
131. Watanabe K., Reddy B.S., Weisburger J.H., Kritchevsky D. Effect of dietary alfalfa, pectin, and wheat bran on azoxymethane- or methylnitrosourea-induced colon carcinogenesis in F344 rats. J. Natl. Cancer Inst. 1979, 63:141-145.
132. Barnes D.S., Clapp N.K., Scott D.A., Oberst D.L., Berry S.G. Effects of wheat, rice, corn, and soybean bran on 1,2-dimethylhydrazine-induced large bowel tumorigenesis in F344 rats. Nutr. Cancer 1983, 5:1-9.
133. Calvert R.J., Klurfeld D.M., Subramaniam S., Vahouny G.V., Kritchevsky D. Reduction of colonic carcinogenesis by wheat bran independent of fecal bile acid concentration. J. Natl. Cancer Inst. 1987, 79:875-880.
134. Alabaster O., Tang Z.C., Frost A., Shivapurkar N. Potential synergism between wheat bran and psyllium: enhanced inhibition of colon cancer. Cancer Lett. 1993, 75:53-58.
135. Alabaster O., Tang Z., Frost A., Shivapurkar N. Effect of beta-carotene and wheat bran fiber on colonic aberrant crypt and tumor formation in rats exposed to azoxymethane and high dietary fat. Carcinogenesis 1995, 16:127-132.
136. Young G.P., McIntyre A., Albert V., Folino M., Muir J.G., Gibson P.R. Wheat bran suppresses potato starch-potentiated colorectal tumorigenesis at the aberrant crypt stage in a rat model. Gastroenterology 1996, 110:508-514.
137. McIntosh G.H., Le Leu R.K., Royle P.J., Young G.P. A comparative study of the influence of differing barley brans on DMH-induced intestinal tumours in male Sprague-Dawley rats. J. Gastroenterol. Hepatol. 1996, 11:113-119.
138. Drankhan K., Carter J., Madl R., Klopfenstein C., Padula F., Lu Y., et al. Antitumor activity of wheats with high orthophenolic content. Nutr. Cancer 2003, 47:188-194.
139. Compher C.W., Frankel W.L., Tazelaar J., Lawson J.A., McKinney S., Segall S., et al. Wheat bran decreases aberrant crypt foci, preserves normal proliferation, and increases intraluminal butyrate levels in experimental colon cancer. J. Parenter. Enteral. Nutr. 1999, 23:269-278.
140. Takahashi T., Satou M., Watanabe N., Sakaitani Y., Takagi A., Uchida K., et al. Inhibitory effect of microfibril wheat bran on azoxymethane-induced colon carcinogenesis in CF1 mice. Cancer Lett. 1999, 141:139-146.
141. Clapp N.K., Henke M.A., London J.F., Shock T.L. Enhancement of 1,2-dimethylhydrazine-induced large bowel tumorigenesis in Balb/c mice by corn, soybean, and wheat brans. Nutr. Cancer 1984, 6:77-85.
142. Jacobs L.R. Enhancement of rat colon carcinogenesis by wheat bran consumption during the stage of 1,2-dimethylhydrazine administration. Cancer Res. 1983, 43:4057-4061.
143. Jacobs L.R., Lupton J.R. Relationship between colonic luminal pH, cell proliferation, and colon carcinogenesis in 1,2-dimethylhydrazine treated rats fed high fiber diets. Cancer Res. 1986, 46:1727-1734.
144. Mutanen M., Pajari A.M., Oikarinen S.I. Beef induces and rye bran prevents the formation of intestinal polyps in Apc(Min) mice: relation to beta-catenin and PKC isozymes. Carcinogenesis 2000, 21:1167-1173.
145. Davies M.J., Bowey E.A., Adlercreutz H., Rowland I.R., Rumsby P.C. Effects of soy or rye supplementation of high-fat diets on colon tumour development in azoxymethane-treated rats. Carcinogenesis 1999, 20:927-931.
146. Oikarinen S., Heinonen S., Karppinen S., Matto J., Adlercreutz H., Poutanen K., et al. Plasma enterolactone or intestinal Bifidobacterium levels do not explain adenoma formation in multiple intestinal neoplasia (Min) mice fed with two different types of rye-bran fractions. Br. J. Nutr. 2003, 90:119-125.
147. van Kranen H.J., Mortensen A., Sorensen I.K., van den Berg-Wijnands J., Beems R., Nurmi T., et al. Lignan precursors from flaxseed or rye bran do not protect against the development of intestinal neoplasia in ApcMin mice. Nutr. Cancer 2003, 45:203-210.
148. Reddy B.S., Maeura Y., Wayman M. Effect of dietary corn bran and autohydrolyzed lignin on 3,2′-dimethyl-4-aminobiphenyl-induced intestinal carcinogenesis in male F344 rats. J. Natl. Cancer Inst. 1983, 71:419-423.
149. Verschoyle R.D., Greaves P., Cai H., Edwards R.E., Steward W.P., Gescher A.J. Evaluation of the cancer chemopreventive efficacy of rice bran in genetic mouse models of breast, prostate and intestinal carcinogenesis. Br. J. Cancer 2007, 96:248-254.
150. Lipkin M., Reddy B., Newmark H., Lamprecht S.A. Dietary factors in human colorectal cancer. Annu. Rev. Nutr. 1999, 19:545-586.
151. Jacobs D.R., Slavin J., Marquart L. Whole grain intake and cancer: a review of the literature. Nutr. Cancer 1995, 24:221-229.
152. Larsson S.C., Giovannucci E., Bergkvist L., Wolk A. Whole grain consumption and risk of colorectal cancer: a population-based cohort of 60,000 women. Br. J. Cancer 2005, 92:1803-1807.
153. Schatzkin A., Mouw T., Park Y., Subar A.F., Kipnis V., Hollenbeck A., et al. Dietary fiber and whole-grain consumption in relation to colorectal cancer in the NIH-AARP Diet and Health Study. Am. J. Clin. Nutr. 2007, 85:1353-1360.
154. Egeberg R., Olsen A., Loft S., Christensen J., Johnsen N.F., Overvad K., et al. Intake of whole grain products and risk of colorectal cancers in the Diet, Cancer and Health cohort study. Br. J. Cancer 2010, 103:730-734.
155. Levi F., Pasche C., La Vecchia C., Lucchini F., Franceschi S. Food groups and colorectal cancer risk. Br. J. Cancer 1999, 79:1283-1287.
156. Boutron-Ruault M.C., Senesse P., Faivre J., Chatelain N., Belghiti C., Meance S. Foods as risk factors for colorectal cancer: a case-control study in Burgundy (France). Eur. J. Cancer Prev. 1999, 8:229-235.
157. Chatenoud L., La Vecchia C., Franceschi S., Tavani A., Jacobs D.R., Parpinel M.T., et al. Refined-cereal intake and risk of selected cancers in Italy. Am. J. Clin. Nutr. 1999, 70:1107-1110.
158. Beresford S.A., Johnson K.C., Ritenbaugh C., Lasser N.L., Snetselaar L.G., Black H.R., et al. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 2006, 295:643-654.
159. Alberts D.S., Martinez M.E., Roe D.J., Guillen-Rodriguez J.M., Marshall J.R., van Leeuwen J.B., et al. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas: Phoenix Colon Cancer Prevention Physicians' Network. N. Engl. J. Med. 2000, 342:1156-1162.
160. Macrae F. Wheat bran fiber and development of adenomatous polyps: evidence from randomized, controlled clinical trials. Am. J. Med. 1999, 106:38S-42S.
161. Lampe J.W., Slavin J.L., Melcher E.A., Potter J.D. Effects of cereal and vegetable fiber feeding on potential risk factors for colon cancer. Cancer Epidemiol. Biomarkers Prev. 1992, 1:207-211.
162. Edenharder R., Sager J.W., Glatt H., Muckel E., Platt K.L. Protection by beverages, fruits, vegetables, herbs, and flavonoids against genotoxicity of 2-acetylaminofluorene and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in metabolically competent V79 cells. Mutat. Res. 2002, 521:57-72.
163. Majer B.J., Hofer E., Cavin C., Lhoste E., Uhl M., Glatt H.R., et al. Coffee diterpenes prevent the genotoxic effects of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and N-nitrosodimethylamine in a human derived liver cell line (HepG2). Food Chem. Toxicol. 2005, 43:433-441.
164. Huber W.W., McDaniel L.P., Kaderlik K.R., Teitel C.H., Lang N.P., Kadlubar F.F. Chemoprotection against the formation of colon DNA adducts from the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the rat. Mutat. Res. 1997, 376:115-122.
165. Huber W.W., Prustomersky S., Delbanco E., Uhl M., Scharf G., Turesky R.J., et al. Enhancement of the chemoprotective enzymes glucuronosyl transferase and glutathione transferase in specific organs of the rat by the coffee components kahweol and cafestol. Arch. Toxicol. 2002, 76:209-217.
166. Huber W.W., Teitel C.H., Coles B.F., King R.S., Wiese F.W., Kaderlik K.R., et al. Potential chemoprotective effects of the coffee components kahweol and cafestol palmitates via modification of hepatic N-acetyltransferase and glutathione S-transferase activities. Environ. Mol. Mutagen. 2004, 44:265-276.
167. Turesky R.J., Richoz J., Constable A., Curtis K.D., Dingley K.H., Turteltaub K.W. The effects of coffee on enzymes involved in metabolism of the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in rats. Chem.-Biol. Interact. 2003, 145:251-265.
168. Lee K.J., Jeong H.G. Protective effects of kahweol and cafestol against hydrogen peroxide-induced oxidative stress and DNA damage. Toxicol. Lett. 2007, 173:80-87.
169. Huber W.W., Scharf G., Rossmanith W., Prustomersky S., Grasl-Kraupp B., Peter B., et al. The coffee components kahweol and cafestol induce gamma-glutamylcysteine synthetase, the rate limiting enzyme of chemoprotective glutathione synthesis, in several organs of the rat. Arch. Toxicol. 2002, 75:685-694.
170. Esposito F., Morisco F., Verde V., Ritieni A., Alezio A., Caporaso N., Fogliano V. Moderate coffee consumption increases plasma glutathione but not homocysteine in healthy subjects. Aliment. Pharmacol. Ther. 2003, 17:595-601.
171. Grubben M.J., Van Den Braak C.C., Broekhuizen R., De Jong R., Van Rijt L., De Ruijter E., et al. The effect of unfiltered coffee on potential biomarkers for colonic cancer risk in healthy volunteers: a randomized trial. Aliment. Pharmacol. Ther. 2000, 14:1181-1190.
172. Yanagimoto K., Ochi H., Lee K.G., Shibamoto T. Antioxidative activities of fractions obtained from brewed coffee. J. Agric. Food Chem. 2004, 52:592-596.
173. Borrelli R.C., Visconti A., Mennella C., Anese M., Fogliano V. Chemical characterization and antioxidant properties of coffee melanoidins. J. Agric. Food Chem. 2002, 50:6527-6533.
174. del Castillo M.D., Ames J.M., Gordon M.H. Effect of roasting on the antioxidant activity of coffee brews. J. Agric. Food Chem. 2002, 50:3698-3703.
175. Mori H., Kawabata K., Matsunaga K., Ushida J., Fujii K., Hara A., et al. Chemopreventive effects of coffee bean and rice constituents on colorectal carcinogenesis. Biofactors 2000, 12:101-105.
176. Jin U.H., Lee J.Y., Kang S.K., Kim J.K., Park W.H., Kim J.G., et al. A phenolic compound, 5-caffeoylquinic acid (chlorogenic acid), is a new type and strong matrix metalloproteinase-9 inhibitor: isolation and identification from methanol extract of Euonymus alatus. Life Sci. 2005, 77:2760-2769.
177. Belkaid A., Currie J.C., Desgagnes J., Annabi B. The chemopreventive properties of chlorogenic acid reveal a potential new role for the microsomal glucose-6-phosphate translocase in brain tumor progression. Cancer Cell Int. 2006, 6:7.
178. Jung J.E., Kim H.S., Lee C.S., Park D.H., Kim Y.N., Lee M.J., et al. Caffeic acid and its synthetic derivative CADPE suppress tumor angiogenesis by blocking STAT3-mediated VEGF expression in human renal carcinoma cells. Carcinogenesis 2007, 28:1780-1787.
179. Kang N.J., Lee K.W., Kim B.H., Bode A.M., Lee H.J., Heo Y.S., et al. Coffee phenolic phytochemicals suppress colon cancer metastasis by targeting MEK and TOPK. Carcinogenesis 2011, 32:921-928.
180. Gosslau A., En Jao D.L., Huang M.T., Ho C.T., Evans D., Rawson N.E., et al. Effects of the black tea polyphenol theaflavin-2 on apoptotic and inflammatory pathways in vitro and in vivo. Mol. Nutr. Food Res. 2011, 55:198-208.
181. Larsen C.A., Dashwood R.H. (-)-Epigallocatechin-3-gallate inhibits Met signaling, proliferation, and invasiveness in human colon cancer cells. Arch. Biochem. Biophys. 2010, 501:52-57.
182. Boffetta P., Hashibe M. Alcohol and cancer. Lancet Oncol. 2006, 7:149-156.
183. Hamid A., Wani N.A., Kaur J. New perspectives on folate transport in relation to alcoholism-induced folate malabsorption: association with epigenome stability and cancer development. FEBS J. 2009, 276:2175-2191.
184. Mori H., Hirono I. Effect of coffee on carcinogenicity of cycasin. Br. J. Cancer 1977, 35:369-371.
185. Carvalho Ddo C., Brigagao M.R., dos Santos M.H., de Paula F.B., Giusti-Paiva A., Azevedo L. Organic and conventional Coffea arabica L.: a comparative study of the chemical composition and physiological, biochemical and toxicological effects in Wistar rats. Plant Foods Hum. Nutr. 2011, 66:114-121.
186. Rao C.V., Chou D., Simi B., Ku H., Reddy B.S. Prevention of colonic aberrant crypt foci and modulation of large bowel microbial activity by dietary coffee fiber, inulin and pectin. Carcinogenesis 1998, 19:1815-1819.
187. Wang R., Dashwood W.M., Lohr C.V., Fischer K.A., Pereira C.B., Louderback M., et al. Protective versus promotional effects of white tea and caffeine on PhIP-induced tumorigenesis and beta-catenin expression in the rat. Carcinogenesis 2008, 29:834-839.
188. Xu M., Bailey A.C., Hernaez J.F., Taoka C.R., Schut H.A., Dashwood R.H. Protection by green tea, black tea, and indole-3-carbinol against 2-amino-3-methylimidazo[4,5-f]quinoline-induced DNA adducts and colonic aberrant crypts in the F344 rat. Carcinogenesis 1996, 17:1429-1434.
189. Caderni G., De Filippo C., Luceri C., Salvadori M., Giannini A., Biggeri A., et al. Effects of black tea, green tea and wine extracts on intestinal carcinogenesis induced by azoxymethane in F344 rats. Carcinogenesis 2000, 21:1965-1969.
190. Challa A., Rao D.R., Reddy B.S. Interactive suppression of aberrant crypt foci induced by azoxymethane in rat colon by phytic acid and green tea. Carcinogenesis 1997, 18:2023-2026.
191. Weisburger J.H., Rivenson A., Aliaga C., Reinhardt J., Kelloff G.J., Boone C.W., et al. Effect of tea extracts, polyphenols, and epigallocatechin gallate on azoxymethane-induced colon cancer. Proc. Soc. Exp. Biol. Med. 1998, 217:104-108.
192. Santana-Rios G., Orner G.A., Xu M., Izquierdo-Pulido M., Dashwood R.H. Inhibition by white tea of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced colonic aberrant crypts in the F344 rat. Nutr. Cancer 2001, 41:98-103.
193. Nelson R.L., Samelson S.L. Neither dietary ethanol nor beer augments experimental colon carcinogenesis in rats. Dis. Colon Rectum 1985, 28:460-462.
194. Hamilton S.R., Hyland J., McAvinchey D., Chaudhry Y., Hartka L., Kim H.T., et al. Effects of chronic dietary beer and ethanol consumption on experimental colonic carcinogenesis by azoxymethane in rats. Cancer Res. 1987, 47:1551-1559.
195. Howarth A.E., Pihl E. High-fat diet promotes and causes distal shift of experimental rat colonic cancer-beer and alcohol do not. Nutr. Cancer 1984, 6:229-235.
196. Nozawa H., Yoshida A., Tajima O., Katayama M., Sonobe H., Wakabayashi K., et al. Intake of beer inhibits azoxymethane-induced colonic carcinogenesis in male Fischer 344 rats. Int. J. Cancer 2004, 108:404-411.
197. Caderni G., Remy S., Cheynier V., Morozzi G., Dolara P. Effect of complex polyphenols on colon carcinogenesis. Eur. J. Nutr. 1999, 38:126-132.
198. Dolara P., Luceri C., De Filippo C., Femia A.P., Giovannelli L., Caderni G., et al. Red wine polyphenols influence carcinogenesis, intestinal microflora, oxidative damage and gene expression profiles of colonic mucosa in F344 rats. Mutat. Res. 2005, 591:237-246.
199. Femia A.P., Caderni G., Vignali F., Salvadori M., Giannini A., Biggeri A., et al. Effect of polyphenolic extracts from red wine and 4-OH-coumaric acid on 1,2-dimethylhydrazine-induced colon carcinogenesis in rats. Eur. J. Nutr. 2005, 44:79-84.
200. Lee K.J., Inoue M., Otani T., Iwasaki M., Sasazuki S., Tsugane S. Coffee consumption and risk of colorectal cancer in a population-based prospective cohort of Japanese men and women. Int. J. Cancer 2007, 121:1312-1318.
201. Je Y., Liu W., Giovannucci E. Coffee consumption and risk of colorectal cancer: a systematic review and meta-analysis of prospective cohort studies. Int. J. Cancer 2009, 124:1662-1668.
202. Zhang X., Albanes D., Beeson W.L., van den Brandt P.A., Buring J.E., Flood A., et al. Risk of colon cancer and coffee, tea, and sugar-sweetened soft drink intake: Pooled analysis of prospective cohort studies. J. Natl. Cancer Inst. 2010, 102:771-783.
203. Galeone C., Turati F., La Vecchia C., Tavani A. Coffee consumption and risk of colorectal cancer: a meta-analysis of case-control studies. Cancer Causes Control 2010, 21:1949-1959.
204. Nilsson L.M., Johansson I., Lenner P., Lindahl B., Van Guelpen B. Consumption of filtered and boiled coffee and the risk of incident cancer: a prospective cohort study. Cancer Causes Control 2010, 21:1533-1544.
205. Peterson S., Yuan J.M., Koh W.P., Sun C.L., Wang R., Turesky R.J., et al. Coffee intake and risk of colorectal cancer among Chinese in Singapore: the Singapore Chinese Health Study. Nutr. Cancer 2010, 62:21-29.
206. Ratnayake W.M., Hollywood R., O'Grady E., Stavric B. Lipid content and composition of coffee brews prepared by different methods. Food Chem. Toxicol. 1993, 31:263-269.
207. Gross G., Jaccaud E., Huggett A.C. Analysis of the content of the diterpenes cafestol and kahweol in coffee brews. Food Chem. Toxicol. 1997, 35:547-554.
208. Urgert R., Van der Weg G., Kosmeiher-Schuil T.G., Van Bovenkamp P., Hovenier R., Katan M.B. Levels of the cholesterol-elevating diterpenes cafestol and kahweol in various coffee brews. J. Agric. Food Chem. 1995, 43:2167-2172.
209. Sun C.L., Yuan J.M., Koh W.P., Yu M.C. Green tea, black tea and colorectal cancer risk: a meta-analysis of epidemiologic studies. Carcinogenesis 2006, 27:1301-1309.
210. Yang G., Shu X.O., Li H., Chow W.H., Ji B.T., Zhang X., et al. Prospective cohort study of green tea consumption and colorectal cancer risk in women. Cancer Epidemiol. Biomarkers Prev. 2007, 16:1219-1223.
211. Shimizu M., Fukutomi Y., Ninomiya M., Nagura K., Kato T., Araki H., et al. Green tea extracts for the prevention of metachronous colorectal adenomas: a pilot study. Cancer Epidemiol. Biomarkers Prev. 2008, 17:3020-3025.
212. Sun C.L., Yuan J.M., Koh W.P., Lee H.P., Yu M.C. Green tea and black tea consumption in relation to colorectal cancer risk: the Singapore Chinese Health Study. Carcinogenesis 2007, 28:2143-2148.
213. Yuan J.M., Gao Y.T., Yang C.S., Yu M.C. Urinary biomarkers of tea polyphenols and risk of colorectal cancer in the Shanghai Cohort Study. Int. J. Cancer 2007, 120:1344-1350.
214. Yang G., Zheng W., Xiang Y.B., Gao J., Li H.L., Zhang X., et al. Green tea consumption and colorectal cancer risk: a report from the Shanghai Men's Health Study. Carcinogenesis 2011, 32:1684-1688.
215. Moskal A., Norat T., Ferrari P., Riboli E. Alcohol intake and colorectal cancer risk: a dose-response meta-analysis of published cohort studies. Int. J. Cancer 2007, 120:664-671.
216. Fedirko V., Tramacere I., Bagnardi V., Rota M., Scotti L., Islami F., et al. Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies. Ann. Oncol. 2011, 22:1958-1972.
217. Lampe J.W. Nutrition and cancer prevention: small-scale human studies for the 21st century. Cancer Epidemiol. Biomarkers Prev. 2004, 13:1987-1988.
218. Lampe J.W. Interindividual differences in response to plant-based diets: implications for cancer risk. Am. J. Clin. Nutr. 2009, 89:1553S-1557S.